The Hidden Financial Risk of Pharmacy: Why CFOs Must Pay Attention | Fatimah Muhammad

The Hidden Financial Risk of Pharmacy: Why CFOs Must Pay Attention | Fatimah Muhammad

Pharmacy financial risk is the operational and reimbursement exposure inside health systems when 340B capture gaps, specialty drug economics, PBM pressure, and revenue cycle disconnects stay invisible to executive leadership until margin compression becomes obvious. Fatimah Muhammad, FHFMA, CHFP, explains why pharmacy has become a strategic financial partner, not a downstream clinical function, and why CFOs can no longer afford to stay on the sidelines of pharmacy strategy, 340B stewardship, and cross-functional visibility.340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how pharmacy, 340B, and reimbursement actually function day to day.In this episode, hosts Muhammad Atif and Nadia Palwasha are joined by Fatimah Muhammad, FHFMA, CHFP, a healthcare executive and public health leader with more than 15 years of experience across 340B strategy, specialty pharmacy, reimbursement optimization, operational excellence, and healthcare financial performance.Fatimah unpacks the hidden financial risk of pharmacy: where operational leakage hides before executive dashboards reflect it, why pharmacy decisions are now enterprise financial decisions, and what CFOs and executive leaders should review monthly instead of waiting for audits or revenue decline.You will hear practical guidance on 340B as revenue cycle strategy, specialty pharmacy opportunity and risk, contract pharmacy economics, PBM and reimbursement pressure, cross-functional alignment across pharmacy, finance, revenue cycle, managed care, and compliance, analytics for earlier risk detection, balancing margin and access, and a 90-day starting framework for executive leaders.0:00:00 Welcome and episode framing: hidden pharmacy financial risk 0:03:15 Co-host introduction: Nadia Palwasha 0:04:45 Guest introduction: Fatimah Muhammad 0:06:10 Guest journey into 340B, specialty pharmacy, and financial performance 0:10:05 Defining hidden financial risk in pharmacy 0:11:18 Why CFOs cannot stay on the sidelines 0:12:45 Operational leakage and executive blind spots 0:13:35 Three CFO visibility pillars: 340B, specialty, contract pharmacy 0:14:22 Executive dashboards and missing operational reality 0:18:30 340B evolution: compliance to revenue cycle strategy 0:23:10 Specialty pharmacy opportunity and risk 0:25:40 Pharmacy reimbursement invisible on standard financial reports 0:28:15 PBM pressures, patient access, and sustainability 0:30:45 Cross-functional alignment: pharmacy, finance, revenue cycle, compliance 0:32:18 Strategic vs reactive pharmacy management signals 0:37:05 Analytics, automation, and earlier risk detection 0:40:20 Balancing financial performance with access and equity 0:44:10 90-day practical steps for CFOs and executive leaders 0:46:30 How to connect with Fatimah Muhammad 0:47:15 Closing and NorthArc CTAWhat is pharmacy financial risk? Pharmacy financial risk is the hidden operational and reimbursement exposure health systems face when 340B capture gaps, specialty drug economics, PBM pressure, denials, and workflow disconnects accumulate without executive visibility.Why should CFOs engage in pharmacy strategy?CFOs should engage because pharmacy sits at the intersection of 340B program performance, specialty service-line economics, contract pharmacy terms, and reimbursement recovery, all of which directly affect enterprise margin and sustainability.What should executives review in the next 90 days? Executives should establish shared visibility into what 340B is generating, how specialty pharmacy margins are performing, whether contract pharmacy economics are actively managed, and a monthly cross-functional review cadence with clear accountability.#340B program, #pharmacy financial risk,#hospital finance, CFO, #specialty pharmacy, #contract pharmacy, #revenue cycle, #PBM

Turning 340B Savings into Patient Access: The Mission Impact Debate | Kalvin Pugh

340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day.In this episode, hosts Muhammad Atif and Nadia Palwasha are joined by Kalvin Pugh, 340B Policy Director, for a grounded conversation on turning 340B savings into mission impact. The discussion explores what happens when savings move beyond financial accounting into real support for low-income, uninsured, and under-resourced patients; the tension between program intent and operational pressure; the gap between savings generated and impact demonstrated; impact versus visibility; patient-level experience in community systems; operational constraints including data and contract pharmacy complexity; evolving frameworks for measuring mission impact; storytelling versus financial reporting; policy standardization; and practical alignment across manufacturers, pharmacies, and covered entities.If your organization needs stronger reporting visibility, operational alignment, and custom agentic automation with compliance guardrails, NorthArc Health helps covered entities modernize 340B operations without losing operator control.0:00:00 Welcome to 340B Pulse and episode framing0:02:20 Co-host intro: 340B savings and patient impact 0:04:10 Guest introduction: Kalvin Pugh0:06:20 Kalvin's journey into 340B and policy0:09:00 Defining "turning savings into mission impact" 0:11:30 Biggest gap: savings generated vs. impact demonstrated 0:14:00 What separates organizations with visible patient impact0:16:30 Impact vs. visibility under manufacturer transparency pressure0:19:30 What patients feel when 340B savings work well 0:22:00 Policy debate vs. patients the program was meant to serve 0:24:30 Challenges translating savings into measurable mission impact 0:27:00 Operational constraints: data, contract pharmacy, reporting 0:29:30 Are mission-impact frameworks mature enough? 0:32:00 Policy intent vs. community-level reality 0:34:30 Patient stories vs. purely financial reporting0:37:00 Policy leaders and standardizing mission impact 0:39:00 Designing a system that connects savings to outcomes 0:39:45 Industry context: AHA pushback on Lilly claims-data policy 0:41:00 Rapid-fire: tracking savings, standardized reporting, future policy 0:43:30 Closing advice: human intent across the 340B ecosystem 0:44:30 How to connect with Kalvin PughWhat is 340B mission impact? 340B mission impact is the measurable patient and community benefit when covered entities use program savings to improve access, continuity of care, and services for vulnerable populations served by safety-net providers.Why is 340B mission impact hard to prove? 340B mission impact is hard to prove because reporting frameworks vary by entity type, data is fragmented across operations, and rising manufacturer transparency requirements add administrative burden that can compete with patient-facing capacity.Is 340B a pricing program or a patient access program? 340B is a federal drug pricing program that covered entities should also treat as a patient access program because its savings are intended to expand care and reduce barriers for underserved populations, not only to improve institutional finances.#340B #340BProgram #PatientAccess #SafetyNet #CoveredEntity #HealthcareCompliance #ContractPharmacy #FQHC #HospitalPharmacy #NorthArcHealth #340BPulse

Claims-Level Data Challenges in 340B: Pharmacy & Medical | Bryan McCormick

340B claims-level data is the patient- and claim-level information covered entities must reconcile across split billing, contract pharmacy, TPAs, EHR outputs, and wholesaler feeds to defend eligibility and program performance. Bryan McCormick explains that most organizations do not have one source of truth, because retail partner mandates can force multiple TPAs, split billing and contract pharmacy remain separate operational worlds, and compliance accountability still rests with the covered entity even when vendors process claims. 340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day. In this episode, host Muhammad Atif is joined by Bryan McCormick, Corporate Director of the 340B Program at RWJBarnabas Health. Bryan unpacks claims-level data challenges across pharmacy and medical-related 340B workflows, including TPA configuration accountability, multi-TPA aggregation burden, split billing versus contract pharmacy separation, garbage-in/garage-out feed discipline, EHR governance, real-world connectivity failures, reconciliation and root-cause expectations, staffing realities for safety-net hospitals, manufacturer portal fragmentation (ESP and related channels), and a practical view of AI and vendor sprawl. If your organization needs stronger claims validation, reporting visibility, and custom agentic automation with compliance guardrails, NorthArc Health helps covered entities modernize 340B operations without losing operator control. 0:00:00 TPA configuration is a covered-entity compliance decision  0:01:08 Multi-TPA reality: Walgreens, CVS, and aggregation burden  0:03:25 Why leadership reports must be 100% accurate  0:04:18 Pharmacy vs medical claims fragmentation in 340B  0:04:38 Split billing vs contract pharmacy: two separate worlds  0:07:15 Garbage in, garbage out and roster discipline 0:09:27 PBMs, TPAs, EHR: volume, variability, and fragmentation  0:10:20 Stakeholder forums and EHR as source of truth  0:12:19 Compliance accountability always on the covered entity  0:13:30 Where data breakdowns occur in handoffs  0:14:21 Pharmacy switch outage case (2024 backlog impact)  0:16:21 Operational impact on eligibility, accumulation, and reporting  0:17:33 Monitoring volume and vendor value  0:19:57 Identification, tracking, and read-only access  0:21:21 Reconciliation, escalation, and self-disclosure thresholds  0:23:29 Scaling, Epic + Verity integration, and KISS operations  0:27:19 Dedicated 340B FTEs and policy volatility  0:28:34 Manufacturer portals: ESP, restrictions, no global playbook  0:30:09 Human review before external manufacturer submissions  0:31:27 AI potential vs integration and PHI risk  0:33:22 More vendors means more integration to police  0:34:36 Practical advice: plug-and-play is over 0:38:05 Stakeholder meetings and how to connect with Bryan What is 340B claims-level data? 340B claims-level data is the detailed claim, eligibility, and feed information covered entities use to run split billing and contract pharmacy workflows, validate vendor outputs, and support compliance, financial reporting, and audit defensibility. Why do covered entities use multiple TPAs? Covered entities often use multiple TPAs because major retail contract pharmacy partners may require their own systems while a primary TPA still supports split billing and other contract relationships, which forces manual aggregation before holistic reporting. Who owns 340B data accuracy when vendors process claims? The covered entity owns compliance and performance accountability in most vendor relationships, which means teams must validate what they send to TPAs and what vendors return before leadership or external reporting. #340B program,#claims data, #pharmacy operations, #healthcare compliance, #split billing,#contract pharmacy, #TPA, #EHR integration, #healthcare data

The 340B “Everything at Once” Problem: What Leaders Can Still Control | Katy F Lees

340B operational control is the covered entity’s ability to maintain audit-ready compliance while also sequencing cross-functional work across pharmacy, finance, informatics, and legal when policies and reimbursement mechanics change quickly. Katy Felice Lees frames this as a leadership and operating discipline problem, not a single-policy problem, because the same compliance words on paper can require different workflows in inpatient, outpatient, mixed-use, and contract pharmacy settings. Strong programs pair transparency with defensible documentation, keep government and internal relationships warm before emergencies, and use data to avoid reactive decision-making.340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day.In this episode, hosts Muhammad Atif and Nadia are joined by Katy Felice Lees, Director of 340B Policy and Business Strategy at the University of Rochester Medical Center and Principal 340B Compliance Advisor with Virtue 340B. Katy discusses what changed as 340B work expanded beyond traditional compliance priorities, why teams describe the current environment as relentlessly urgent, and what “control” means when organizations must prepare for policy paths that may pivot late. 0:01:12 Opening: why 340B Pulse exists and today’s topic 0:04:22 Katy’s journey from pharmacy technician to leading a 14-person 340B team 0:06:43 What feels most different operationally versus a few years ago 0:08:50 The current operational reality: urgency without pause 0:09:31 Defining control: what you can manage versus what you cannot 0:11:01 Leadership control: stewardship, narrative, relationships, budget cycles 0:13:02 Overreacting vs under-preparing when information is still forming 0:15:50 Compliance vs operational control: duplicate discounts in the real world 0:18:27 Child-site developments: opportunity, mindfulness, transparency 0:21:09 GPO prohibition: constraints embedded in daily infrastructure 0:23:44 Rebate model noise: what leaders should focus on underneath 0:26:11 Internal discipline: cross-functional cadence and ownership 0:29:22 Signals of strong control vs slipping control 0:31:01 Data access, informatics, and realistic AI expectations 0:32:21 Staying current: trusted sources and conferences 0:35:39 Advice for covered entity leaders for the next 6 to 12 months 0:36:49 How to connect with Katy Felice Lees and Virtue 340BWhat is 340B operational control? 340B operational control is the organization’s combined ability to keep core compliance stable, validate workflows in real settings, and coordinate pharmacy, finance, informatics, and legal decisions when external requirements change quickly, without losing sight of cash flow, documentation, and accountability.Why does “compliance on paper” fail teams during audits and manufacturer interactions?Compliance language fails when it does not match tested workflows, because duplicate discount prevention and similar obligations become configuration, modifiers, carve logic, and continuous monitoring that differ by site type and vendor setup.How should leaders prepare for rebate-model mechanics even when policy timing shifts? Leaders should prepare by clarifying upfront purchase and rebate timing impacts on cash flow, assigning ownership for data submission and reconciliation, learning from MFP and manufacturer data-policy experiences, and building cross-functional runbooks rather than assuming a single vendor will interpret organizational risk.#340B, #340B program, #covered entity, #hospital pharmacy, #pharmacy operations, healthcare compliance, duplicate discounts, #GPO prohibition, 340B policy, drug pricing, Medicare, #MFP

More Work, Same Teams: How 340B Leaders Prioritize Risk, Leakage, and Growth | Eric Mitchell

340B operational readiness is the practical ability of a covered entity to execute 340B compliance, data visibility, and cross-team workflow ownership continuously, even as MFP and rebate-related responsibilities increase, without relying on last-minute scrambles. In this episode of 340B Pulse, Eric Mitchell explains why most failures are not caused by policy confusion, but by ownership, work design, handoffs, and low-quality inputs that technology cannot fix.In this episode of 340B Pulse, NorthArc’s Muhammad Atif and Hassaan sit down with Eric Mitchell to unpack a reality covered entity teams are living every day: more complexity, more data requirements, and more platforms, but the same staffing and the same operational bandwidth.We break down what has changed operationally inside covered entities as Medicare Maximum Fair Price (MFP) becomes an operational reality and rebate-related workflows push new responsibilities downstream. Eric shares a practical prioritization sequence for leaders who know change is coming but have limited capacity: protect irreversible risk first, identify leakage in process or revenue second, and then decide what to solve long-term so you are not perpetually firefighting.We also discuss where technology genuinely removes burden through visibility and data aggregation, where expectations become unrealistic, and why “garbage in, garbage out” still governs analytics, models, and AI. Finally, we cover why HIPAA and privacy guardrails are shaping how healthcare organizations adopt AI, often through controlled internal approaches.NorthArc helps covered entities strengthen visibility, improve ESP and Beacon readiness, reduce operational burden, and enhance audit defensibility without disrupting existing TPAs or workflows. 00:00 - Cold open on flexibility, complexity, and MFP01:19 - 340B Pulse introduction and why operator-level conversations matter03:09 - Guest introduction: Eric Mitchell and his 340B journey08:05 - What changed for covered entities: workload, flexibility, and interconnected work09:41 - Where execution breaks down: ownership and work design11:01 - MFP as operational reality and what teams underestimate12:36 - Prioritization under pressure: risk, leakage, and capability15:09 - Technology, AI, and the limits of tools without process discipline17:03 - Trusting calculators and models: validate assumptions and pressure test18:20 - Leadership and change: supporting people so strategy works23:58 - Where leaders should start: networks, SWOT, and not doing it alone27:11 - Wrap up Q: What is 340B operational readiness? A: 340B operational readiness is the continuous ability to execute patient eligibility, claim validation, audit defensibility, and stakeholder ownership with reliable data and disciplined workflows, even as MFP and rebate responsibilities add operational load.Q: Why do 340B programs break down operationally even when policies are understood? A: 340B programs often break down because ownership and work design are unclear, cross-team handoffs are fragile, and data inputs are inconsistent, which creates execution gaps that tools and platforms cannot automatically correct.Q: How should a covered entity prioritize work when bandwidth is limited? A: A covered entity should prioritize by protecting irreversible risk first, then identifying leakage in process or revenue second, and finally investing in long-term capability so recurring problems are solved once instead of repeatedly firefought.#340B, #340B Program, #MFP, Medicare Maximum Fair Price, #340B Operations, #Healthcare Compliance, #Pharmacy Operations,# Healthcare Operations, #Audit Readiness,# Data Governance, #Healthcare AI, #NorthArc Health,, #Eric Mitchell